Skip to content

SPRYARS PHARMACEUTICALS INC

CUSIP 82835W108 · common stock

3 tracked investors held ARS PHARMACEUTICALS INC (SPRY) at the end of Q3 2026, worth $53.5M in total. The largest holder was RA Capital Management, with 0.5% of its portfolio. Chuck Royce sold out of its position this quarter.

Holders · Q3 2026
3
New holders
0
Value held
$53.5M
Quarter-end price (est.)
$4.31

Investors holding SPRY · Q3 2026

InvestorWeightSharesValueChange
RA Capital Management
RA Capital Management, L.P.
0.47%10,860,977$46.8MHOLD
Daniel Loeb
Third Point LLC
0.09%1,000,000$4.3MHOLD
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.10%560,999$2.4MREDUCE-6.7%

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Chuck Royce0.00%54,024$432.7KEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026301$53.5M$4.31
Q2 2026401$100.3M$8.01
Q1 2026500$116.8M$8.03
Q4 2025500$154.5M$11.65